Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1202602
Max Phase: Preclinical
Molecular Formula: C28H36Cl2N2O7
Molecular Weight: 510.59
Molecule Type: Small molecule
Associated Items:
ID: ALA1202602
Max Phase: Preclinical
Molecular Formula: C28H36Cl2N2O7
Molecular Weight: 510.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc([C@@H]2c3cc4c(cc3[C@@H](CCN3CCN(C)CC3)C3COC(=O)[C@@H]32)OCO4)cc(OC)c1O.Cl.Cl
Standard InChI: InChI=1S/C28H34N2O7.2ClH/c1-29-6-8-30(9-7-29)5-4-17-18-12-21-22(37-15-36-21)13-19(18)25(26-20(17)14-35-28(26)32)16-10-23(33-2)27(31)24(11-16)34-3;;/h10-13,17,20,25-26,31H,4-9,14-15H2,1-3H3;2*1H/t17-,20?,25-,26+;;/m1../s1
Standard InChI Key: NPOUZOXMXCBXOS-GOMVEAPESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 510.59 | Molecular Weight (Monoisotopic): 510.2366 | AlogP: 2.79 | #Rotatable Bonds: 6 |
Polar Surface Area: 89.93 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.36 | CX Basic pKa: 8.19 | CX LogP: 2.29 | CX LogD: 1.63 |
Aromatic Rings: 2 | Heavy Atoms: 37 | QED Weighted: 0.59 | Np Likeness Score: 0.69 |
1. Terada T, Fujimoto K, Nomura M, Yamashita J, Wierzba K, Yamazaki R, Shibata J, Sugimoto Y, Yamada Y, Kobunai T.. (1993) Antitumor agents. 3. Synthesis and biological activity of 4 beta-alkyl derivatives containing hydroxy, amino, and amido groups of 4'-O-demethyl-4-desoxypodophyllotoxin as antitumor agents., 36 (12): [PMID:8389875] [10.1021/jm00064a002] |
Source(1):